We would love to hear your thoughts about our site and services, please take our survey here.
Https://www.bbc.co.uk/news/uk-wales-66735012
Think this also came up on local SW news. Lack of availability of weight loss drugs for diabetics. Obvious opportunity for Opti. Article even says, drug popular as suppresses appetite. Also, these patients have associated blood pressure problems (PBX).
Further to other post. Overwhelming impression was that nearly the whole shop was aimed at gut health. With SlimExpert (SlimBiome) a small, difficult to find display. ** But the very helpful assistant said lots more slimming products online. I asked her what she knew about SlimBiome and she said they'd been given training on it about 3 years ago. She also said a lot of customers didn't really ask if products were backed by scientific trials. I told her about WellBiome and LeanBiome which were not in store. Also told her about Cholbiome, which I didn't expect to see. And indeed, SweetBiome. She was extremely polite and thanked me for extending her education. Poor girl!!
** In same display were competitors BoomBod and XLS (?). And someone else's gummies too.
Just been in Marks in Plymurf. Big sign advertising the Zoe gut shot. So, decided to go in H&B. SlimBiome hidden at back of store, but did have a small display card explaining the clinical backing. More to follow on H&B experience.
Happy New Year's eve. On checking, I think I have held Opti for 5.5 years. I was first drawn to the company via an article in a newspaper. At that time, the focus was probably on SlimBiome. So perhaps I liked the idea that a slimming product had science backing it up. But as time went on I became more of a fan of LPLDL /Probiotix. And of course in the background, we have the carrot (or sweety).
SlimBiome appears to be holding its own, in a very crowded market. Backed by what appear to be some promising deals abroad. SBTX and more recently PBX, have been cut adrift, and we now have to rely on the two SAs being able to build on what SOH oversaw. In again, increasingly crowded markets. Though not as crowded as slimming. And for SweetBiotix, we are having to show unending patience. Ditto Microbiome Modulators.
As far as SOH is concerned, my impression is that he is a genuine person. He can be a bit vague regarding the value of deals made and timescales for new products. But he is a canny operator, having run this company for well over 10 years, with no debt and very little dilution. Though SBTX holders will be irked by his sale of Opti's stake in the former.
I will continue to hold, at a loss (ave=mid 50s)in the hope that SweetBiotix starts to bear fruit, sweets or carrots. But the longer Sweet takes, the more competition in the natural sweet fibres market. And the less ultimate reward.
For info, I hold Opti, PBX and SBTX. My Opti holding is much greater than PBX and SBTX, though none is particularly large. Having held various FTSE 100 and AIM shares, these are my remaining holdings. I have just been offered 5.8% on renewal of an NS&I savings product for 3 years. And that is a certainty! IMO most AIM shares are an expensive hobby/gamble. And most AIM CEOs are greedy, overpaid and nowhere near what they are cracked up to be.
What a load of old waffle!! :) Sorry, not much on telly and weather awful. Cheers MU.
Perhaps wishful interpretation of "in due course" by me. As a matter of interest, "whispering Steve" put out a podcast type broadcast on Soundcloud between Christmas and New Year last year. Further straw clutching? Merry Christmas one and all.
Mol, interesting article and, as you say, competition from a big player. Our SlimBiome, etc products are in a very crowded market. Though perhaps not so much if you take into account science/trials evidence. Of which we have a few.
Also, potential competition to PBX, though Nestlé didn't attach numbers to cholesterol improvement.
FS, I was expecting /hoping for an update like you. Before calendar year end. But pretty unlikely now I suppose.
If SweetBiotix is a good product it needs to get to market. Competitors won't wait forever to launch alternatives. C'mon SOH !!
A reply to my email.
Apologies for the delay. I was on holiday when you sent the original email and it fell under my radar after I got back. The Company is working constantly on delivering milestones and increasing liquidity. The latter is difficult in these markets, but they have a defined strategy in place. For your information, we intend to hold an investor presentation (hosted on the IMC platform) in the New Year where Steen will lay out the plans for 2024 and how he and the Board plan to delivery growth.
Clio, I too am concerned. I think trying to defend the salaries of the CEO and CFO, is trying to defend the indefensible. Given the current level of revenues.
And if the CFO has no staff, what is he chief of?
But, as I've said before, SBTX is very much not alone on AIM, having to fund raise to pay admin. And having "chiefs" who are paid way too much in mainly loss making companies. In the meantime these "chiefs" have to be positive in public to keep shareholders on side.
This is another company with potentially great products, which may or may not turn a profit one day.
Perhaps these AIM chiefs should take a leaf out of shareholders' books and exercise patience with regard to remuneration.